Aadil S Inamdar1, Raymond E Croucher2, Mrunalini K Chokhandre3, Mohammed H Mashyakhy4, Valeria C C Marinho5. 1. Department of Preventive Dental Sciences, College of Dentistry, Jazan University, Jazan, Kingdom of Saudi Arabia; aadil.si@gmail.com. 2. Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, London, UK; 3. Department of Clinical Pharmacology, Faculty of Medicine, Jazan University, Jazan, Kingdom of Saudi Arabia; 4. Department of Restorative Dental Sciences, College of Dentistry, Jazan University, Jazan, Kingdom of Saudi Arabia; 5. Centre for Clinical and Diagnostic Oral Sciences, Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Abstract
BACKGROUND: Perinatal morbidity and mortality are important indicators of maternal health and the future health of the child. Smokeless tobacco (ST) use during pregnancy is associated with low birth weight (LBW), preterm births, stillbirths, and small for gestation age (SGA). This study systematically reviews and summarizes evidence on the association of maternal ST use with these adverse health outcomes in newborns. METHODS: Electronic databases (Medline, Embase, Lilacs) were searched in July 2013 using appropriate keywords complemented with reference list searching. Observational studies of maternal ST use and these outcomes were considered; LBW, preterm, stillbirth, SGA. A comprehensive assessment of quality and risk of bias in all included studies was performed. RevMan software was used for data analysis. Results are expressed as crude odds ratios with 95% confidence intervals. Chi-square and I(2) tests checked for heterogeneity and quantified inconsistency between results. RESULTS: There were 9 studies (16 reports) included (7 cohort-studies, 1 case-control study, and 1 cross-sectional study). They were clinically and methodologically diverse. Significant associations with ST use were seen in 5/7 studies for LBW, in 3/6 studies for preterm, in all 4 studies for stillbirth and in 1/2 studies assessing SGA. Heterogeneity between results was moderate for LBW (I(2) = 44%) and stillbirth (I(2) = 52%), and high for preterm (I(2) = 87%) and SGA (I(2) = 65%). Meta-analysis was considered inappropriate due to risk of bias and confounding. CONCLUSIONS: Although most studies show an association between ST use in pregnancy and adverse health effects in newborns, these results may be limited by confounding and bias. Quality observational studies are needed to strengthen this evidence base.
BACKGROUND: Perinatal morbidity and mortality are important indicators of maternal health and the future health of the child. Smokeless tobacco (ST) use during pregnancy is associated with low birth weight (LBW), preterm births, stillbirths, and small for gestation age (SGA). This study systematically reviews and summarizes evidence on the association of maternal ST use with these adverse health outcomes in newborns. METHODS: Electronic databases (Medline, Embase, Lilacs) were searched in July 2013 using appropriate keywords complemented with reference list searching. Observational studies of maternal ST use and these outcomes were considered; LBW, preterm, stillbirth, SGA. A comprehensive assessment of quality and risk of bias in all included studies was performed. RevMan software was used for data analysis. Results are expressed as crude odds ratios with 95% confidence intervals. Chi-square and I(2) tests checked for heterogeneity and quantified inconsistency between results. RESULTS: There were 9 studies (16 reports) included (7 cohort-studies, 1 case-control study, and 1 cross-sectional study). They were clinically and methodologically diverse. Significant associations with ST use were seen in 5/7 studies for LBW, in 3/6 studies for preterm, in all 4 studies for stillbirth and in 1/2 studies assessing SGA. Heterogeneity between results was moderate for LBW (I(2) = 44%) and stillbirth (I(2) = 52%), and high for preterm (I(2) = 87%) and SGA (I(2) = 65%). Meta-analysis was considered inappropriate due to risk of bias and confounding. CONCLUSIONS: Although most studies show an association between ST use in pregnancy and adverse health effects in newborns, these results may be limited by confounding and bias. Quality observational studies are needed to strengthen this evidence base.
Authors: Christi A Patten; Harry A Lando; Chris A Desnoyers; Yvette Barrows; Joseph Klejka; Paul A Decker; Christine A Hughes; Martha J Bock; Rahnia Boyer; Kenneth Resnicow; Linda Burhansstipanov Journal: Contemp Clin Trials Date: 2019-01-28 Impact factor: 2.226
Authors: Renee D Goodwin; Keely Cheslack-Postava; Deborah B Nelson; Philip H Smith; Deborah S Hasin; Teresa Janevic; Nina Bakoyiannis; Melanie M Wall Journal: Nicotine Tob Res Date: 2017-05-01 Impact factor: 4.244
Authors: Alfgeir L Kristjansson; Ingibjorg E Thorisdottir; Thora Steingrimsdottir; John P Allegrante; Christa L Lilly; Inga D Sigfusdottir Journal: Eur J Public Health Date: 2017-10-01 Impact factor: 3.367
Authors: Christi A Patten; Harry Lando; Kenneth Resnicow; Paul A Decker; Christina M Smith; Marcelo M Hanza; Linda Burhansstipanov; Matthew Scott Journal: J Commun Healthc Date: 2018-07-16
Authors: Shannon Gravely; Geoffrey T Fong; Pete Driezen; Steve Xu; Anne C K Quah; Genevieve Sansone; Prakash C Gupta; Mangesh S Pednekar Journal: BMC Public Health Date: 2016-12-13 Impact factor: 3.295